BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 30, Issue 35
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (6045)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.
Item 
Count 
PDF168
HTML3766
Figures (1-2)427
Tables (1-1)483
 Sum=4844
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse226
Download688
 Sum=914
Sep 21, 2024 (publication date) through Feb 9, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Caballero-Mateos AM, Cañadas-de la Fuente GA. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World J Gastroenterol 2024; 30(35): 3942-3953 [PMID: 39351053 DOI: 10.3748/wjg.v30.i35.3942]
URL: https://www.wjgnet.com/2307-8960/full/v30/i35/3942.htm
Number Citing Articles
1
Viviana Parra-Izquierdo, Juan Sebastián Frías-Ordoñez, Fabio Leonel Gil-Parada, William Otero-Regino, Jonathan Barreto Perez, German Manuel Tovar Fierro, Fabian Eduardo Puentes-Manosalva, Pedro Eduardo Cuervo Pico, María Teresa Galiano, Javier Riveros, Alvaro Andrés Gomez-Venegas, Carlos Andrés Medrano Almanza, Daniel Perea, Manuel Ballesteros, Carlos Augusto Cuadros Mendoza, Cristian Florez-Sarmiento. Experiencia en mundo real con el uso de upadacitinib en inducción para enfermedad inflamatoria intestinal en Colombia: uparecol-induction. Revista de Gastroenterología del Perú 2025; 45(3): 255 doi: 10.47892/rgp.2025.453.1904
2
Hongkun Li, Yuyue Zhang, Simin Du, Jinghan Shen, Xingyan Liu, Jie Jing. “Remodeling the intestinal immune microenvironment”: immune regulation and tissue regeneration by mesenchymal stem/stromal cells in the repair microenvironment of inflammatory bowel disease. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1543702
3
Antonio M Caballero-Mateos, Claudio Trigo-Salado, Álvaro Suárez-Toribio, María del Mar Martín-Rodríguez, Francisco J Rodríguez-González, Teresa Valdés-Delgado, Héctor Pallarés-Manrique, Ana María Trapero-Martínez, Raúl Olmedo-Martín, Cristina Bailón-Gaona, José Manuel Benitez Cantero, B Gros, Antonia Sáez-Díaz, Álvaro Hernández-Martínez. Long-term clinical outcomes with filgotinib in ulcerative colitis: 12-month results from the FILGUITO study. World Journal of Gastroenterology 2026; 32(6): 115941 doi: 10.3748/wjg.v32.i6.115941
4
Aleksandar Radlović, Teodora Safiye, Elvis Mahmutović. The use of corticosteroids in the treatment of ulcerative colitis: A brief overview. Arhiv za farmaciju 2025; 75(3): 167 doi: 10.5937/arhfarm75-57020
5
Muhammad Umar Ahsan, Syeda Laiba Sajid, Rahul Balach, Muhammad Daniyal, Noor Ul Ain, Muhammad Mudasir. Emerging role of Janus kinase inhibitors in ulcerative colitis management. World Journal of Gastrointestinal Pharmacology and Therapeutics 2025; 16(4): 110472 doi: 10.4292/wjgpt.v16.i4.110472
6
Antonio M. Caballero-Mateos, Eduard Brunet-Mas, Beatriz Gros. Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations. Journal of Clinical Medicine 2025; 14(22): 7984 doi: 10.3390/jcm14227984
7
Genetic Regulation of Immune Response Pathways. Advances in Genetics 2026; 115: 229 doi: 10.1016/bs.adgen.2025.11.008
8
Antonio M. Caballero Mateos, Guillermo A. Cañadas de la Fuente, Beatriz Gros. Paradigm Shift in Inflammatory Bowel Disease Management: Precision Medicine, Artificial Intelligence, and Emerging Therapies. Journal of Clinical Medicine 2025; 14(5): 1536 doi: 10.3390/jcm14051536
9
Md. Mizanur Rahaman, Phurpa Wangchuk, Subir Sarker, Qingdong Guan. Targeting Interferon‐Gamma (IFN‐γ)‐Related Signalling Pathways in Inflammatory Bowel Disease: Emerging Inhibitors and Therapeutic Advances. Mediators of Inflammation 2025; 2025(1) doi: 10.1155/mi/3181200
10
Duaa A. Althumairy, Rasha Abu-Khudir, Afnan I. Alandanoosi, Gehan M. Badr. Garlic Peel-Derived Phytochemicals Using GC-MS: Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Effects in Ulcerative Colitis Rat Model. Pharmaceuticals 2025; 18(7): 969 doi: 10.3390/ph18070969
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345